Diagnostics & Research
The Diagnostics & Research industry has a total of 46 stocks, with a combined market cap of $810.06 billion, total revenue of $173 billion and a weighted average PE ratio of 45.13.
Market Cap
810.06B
Revenue
173B
Profits
17.95B
PE Ratio
45.13
Profit Margin
10.37%
Dividend Yield
0.20%
46 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 217.52B | -1.28% | 1,057,645 | 46.34B |
| 2 | DHR | Danaher Corporation | 142.32B | -0.71% | 2,244,465 | 25.11B |
| 3 | NTRA | Natera, Inc. | 44.67B | -0.27% | 1,273,563 | 2.71B |
| 4 | IDXX | IDEXX Laboratories, Inc. | 43.41B | -2.82% | 453,501 | 4.55B |
| 5 | A | Agilent Technologies, Inc. | 41.95B | -0.51% | 983,112 | 7.23B |
| 6 | WAT | Waters Corporation | 40.49B | -0.32% | 387,603 | 4.64B |
| 7 | IQV | IQVIA Holdings Inc. | 38.95B | -2.01% | 905,609 | 16.98B |
| 8 | ILMN | Illumina, Inc. | 28.82B | -0.91% | 993,013 | 4.49B |
| 9 | MTD | Mettler-Toledo International Inc. | 28.43B | -0.82% | 162,020 | 4.13B |
| 10 | DGX | Quest Diagnostics Incorporated | 25.87B | -0.69% | 541,800 | 11.56B |
| 11 | LH | Labcorp Holdings Inc. | 25.80B | -1.38% | 436,290 | 14.35B |
| 12 | GH | Guardant Health, Inc. | 21.10B | -1.46% | 2,564,771 | 1.18B |
| 13 | MEDP | Medpace Holdings, Inc. | 16.15B | -0.59% | 220,617 | 2.78B |
| 14 | CRL | Charles River Laboratories International, Inc. | 13.37B | -0.43% | 750,354 | 4.00B |
| 15 | RVTY | Revvity, Inc. | 13.04B | -0.56% | 774,553 | 2.91B |
| 16 | ICLR | ICON Public Limited Company | 12.59B | -2.59% | 323,992 | 8.29B |
| 17 | QGEN | Qiagen N.V. | 8.88B | -0.65% | 3,673,766 | 2.10B |
| 18 | TWST | Twist Bioscience Corporation | 7.44B | -5.36% | 1,140,424 | 431.80M |
| 19 | RDNT | RadNet, Inc. | 6.01B | -1.24% | 632,875 | 2.27B |
| 20 | SHC | Sotera Health Company | 5.39B | -0.68% | 1,558,423 | 1.22B |
| 21 | BLLN | BillionToOne, Inc. | 4.40B | -0.75% | 480,856 | 397.41M |
| 22 | ADPT | Adaptive Biotechnologies Corporation | 3.95B | 1.14% | 1,743,591 | 308.08M |
| 23 | VCYT | Veracyte, Inc. | 3.32B | -3.17% | 1,669,301 | 561.90M |
| 24 | GRAL | GRAIL, Inc. | 3.03B | -0.54% | 433,178 | 165.26M |
| 25 | CDNA | CareDx, Inc. | 2.34B | -4.35% | 708,978 | 458.09M |
| 26 | WGS | GeneDx Holdings Corp. | 2.33B | -1.35% | 391,845 | 454.43M |
| 27 | NEO | NeoGenomics, Inc. | 2.05B | -2.75% | 905,966 | 766.30M |
| 28 | PSNL | Personalis, Inc. | 1.50B | -2.64% | 1,042,604 | 69.67M |
| 29 | FRNM | Freenome, Inc. | 1.30B | -0.43% | 775,639 | 34.24M |
| 30 | OPK | OPKO Health, Inc. | 1.03B | -1.43% | 3,284,020 | 587.90M |
| 31 | CSTL | Castle Biosciences, Inc. | 904.88M | -3.04% | 264,210 | 357.28M |
| 32 | FLGT | Fulgent Genetics, Inc. | 510.68M | -0.48% | 140,467 | 323.93M |
| 33 | MYGN | Myriad Genetics, Inc. | 289.82M | -4.42% | 1,555,152 | 806.60M |
| 34 | BDSX | Biodesix, Inc. | 253.23M | 0.88% | 72,411 | 102.94M |
| 35 | XGN | Exagen Inc. | 161.34M | 1.22% | 154,181 | 71.12M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 141.37M | 16.44% | 331,435 | 1.67M |
| 37 | QUCY | Quantum Cyber N.V. | 124.00M | 3.87% | 862,526 | 537.08K |
| 38 | BNR | Burning Rock Biotech Limited | 93.12M | -4.95% | 16,097 | 74.58M |
| 39 | PRPO | Precipio, Inc. | 42.00M | 1.25% | 75,808 | 27.20M |
| 40 | MDXH | MDxHealth SA | 41.50M | 74.89% | 326,588,781 | 114.02M |
| 41 | ADVB | Advanced Biomed Inc. | 14.79M | 4.31% | 486,485 | - |
| 42 | MBAI | Check-Cap Ltd. | 9.63M | -1.25% | 28,281 | - |
| 43 | XWEL | XWELL, Inc. | 8.28M | -2.97% | 10,952 | 28.28M |
| 44 | NDRA | ENDRA Life Sciences Inc. | 5.68M | - | 52,220 | - |
| 45 | ISPC | iSpecimen Inc. | 5.48M | -2.17% | 40,250 | 466.30K |
| 46 | BIAF | bioAffinity Technologies, Inc. | 3.26M | 4.99% | 508,104 | 5.90M |